Intestinal permeability test in systemic lupus erythematosus.

Area of Science:

• Gastroenterology
• Immunology
• Clinical Diagnostics

Background:

• Intestinal permeability is a key factor in gastrointestinal health.
• Systemic lupus erythematosus (SLE) is an autoimmune disease with potential systemic manifestations.
• Assessing intestinal permeability may offer insights into SLE pathophysiology.

Purpose of the Study:

• To evaluate the utility of the Cr-51 EDTA intestinal permeability test in distinguishing SLE patients from healthy individuals.
• To investigate potential alterations in intestinal permeability in SLE patients.

Main Methods:

• Utilized the Cr-51 labeled EDTA resorption test, a validated method for measuring intestinal permeability.
• Recruited 23 patients diagnosed with SLE and 16 healthy volunteers for comparison.
• Adopted the Cr-51 EDTA intestinal permeability test methodology from Bjarnason et al. (Gastroenterology 1983; 85:318).

Main Results:

• 87% of healthy controls exhibited abnormal intestinal permeability test findings (excretion > 2.6% in 24h).
• No statistically significant difference in Cr-51 EDTA excretion was observed between SLE patients (3.51 +/- 1.66) and healthy controls (4.20 +/- 1.56).
• The test failed to show a significant difference between the study groups.

Conclusions:

• The Cr-51 EDTA intestinal permeability test is not a reliable method for differentiating between SLE patients and healthy individuals.
• The high prevalence of abnormal results in the control group raises concerns about the test's overall validity and interpretation.
• Further research is needed to explore reliable biomarkers for intestinal permeability in autoimmune diseases like SLE.